Stock RDHL REDHILL BIOPHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company RedHill Biopharma Ltd.

Equities

RDHL

US7574682024

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 02:00:00 01/05/2024 am IST 		5-day change 1st Jan Change
0.4313 USD -0.39% Intraday chart for RedHill Biopharma Ltd. +0.82% -70.46%
24/04 RedHill Biopharma Ltd Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study CI
08/04 RedHill Biopharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.

Number of employees: 53

Sales per Business

USD in Million2022Weight2023Weight Delta
Commercial
100.0 %
62 100.0 % 7 100.0 % -89.43%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
62 100.0 % 7 100.0 % -89.43%

Managers

Managers TitleAgeSince
Dror Ben-Asher CEO
 Chief Executive Officer 59 03/09/03
Ori Shilo FOU
 Founder 58 03/09/03
Razi Ingber DFI
 Director of Finance/CFO - 05/23/05
Gilead Raday COO
 Chief Operating Officer 49 10/10/10
Ira N. Kalfus CTO
 Chief Tech/Sci/R&D Officer 63 -
Reza Fathi CTO
 Chief Tech/Sci/R&D Officer 69 01/10/01
kristin Comer CMP
 Compliance Officer - -
June Almenoff CTO
 Chief Tech/Sci/R&D Officer 67 28/19/28
Mark L. Levitt CTO
 Chief Tech/Sci/R&D Officer - 01/17/01
Terry F. Plasse CTO
 Chief Tech/Sci/R&D Officer - -

Members of the board

Members of the board TitleAgeSince
Rick Scruggs BRD
 Director/Board Member 64 01/16/01
Shmuel Cabilly BRD
 Director/Board Member 74 26/10/26
Eric Emile Swenden BRD
 Director/Board Member 80 03/10/03
Alla Felder BRD
 Director/Board Member 50 06/19/06
Dror Ben-Asher CEO
 Chief Executive Officer 59 03/09/03
Kenneth Reed BRD
 Director/Board Member 70 15/09/15
Ofer Tsimchi BRD
 Director/Board Member 64 04/11/04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 7,869,853,000 7,791,154,470 ( 99.00 %) 0 99.00 %

Shareholders

NameEquities%Valuation
Heights Capital Management, Inc.
5.892 %
1,750,000 5.892 % 927 500 $
Gagnon Securities LLC
0.3016 %
89,589 0.3016 % 47 482 $
Jane Street Group LLC
0.2923 %
86,812 0.2923 % 46 010 $
RhumbLine Advisers LP
0.1173 %
34,847 0.1173 % 18 469 $
MGO One Seven LLC
0.0530 %
15,750 0.0530 % 8 348 $
Squarepoint OPS LLC
0.0369 %
10,947 0.0369 % 5 802 $
Group One Trading LP
0.002070 %
615 0.002070 % 326 $
Morgan Stanley Capital Services LLC
0.001939 %
576 0.001939 % 305 $
Aspire Private Capital LLC
0.001367 %
406 0.001367 % 215 $
Yorkville Asset Management, Inc.
0.001209 %
359 0.001209 % 190 $
NameEquities%Valuation
R&S United Services, Inc.
17.09 %
2,030,472,000 17.09 % 108 M $
Kenneth Reed
0.0657 %
7,805,250 0.0657 % 413 678 $
Shmuel Cabilly
0.0438 %
5,201,270 0.0438 % 275 667 $
Dror Ben-Asher
0.0329 %
3,910,620 0.0329 % 207 263 $
Adi Frish
0.0223 %
2,650,720 0.0223 % 140 488 $
Gilead Raday
0.0206 %
2,448,400 0.0206 % 129 765 $
Reza Fathi
0.0152 %
1,800,800 0.0152 % 95 442 $
Razi Ingber
0.0141 %
1,678,800 0.0141 % 88 976 $
Guy Goldberg
0.0139 %
1,645,600 0.0139 % 87 217 $
Intracoastal Capital LLC
0.0105 %
1,250,000 0.0105 % 66 250 $

Company contact information

RedHill Biopharma Ltd.

21 Ha'arba'a Street

6473921, Tel Aviv

+972 3 541 3131

http://www.redhillbio.com
address RedHill Biopharma Ltd.(RDHL)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
REDHILL BIOPHARMA LTD. Stock RedHill Biopharma Ltd.
-70.46% 13.74M
CSL LIMITED Stock CSL Limited
-4.07% 86.85B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.76% 40.16B
BIOGEN INC. Stock Biogen Inc.
-16.98% 31.28B
UCB Stock UCB
+57.86% 25.27B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.24% 15.33B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.12% 11.96B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-42.56% 11.61B
INCYTE CORPORATION Stock Incyte Corporation
-17.10% 11.69B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+6.89% 8.83B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. RDHL Stock
  4. Company RedHill Biopharma Ltd.